123 related articles for article (PubMed ID: 7680216)
1. Identification of a tumor marker chromosome by flow sorting, DNA amplification in vitro, and in situ hybridization of the amplified product.
Boschman GA; Buys CH; van der Veen AY; Rens W; Osinga J; Slater RM; Aten JA
Genes Chromosomes Cancer; 1993 Jan; 6(1):10-6. PubMed ID: 7680216
[TBL] [Abstract][Full Text] [Related]
2. Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines.
Bruch J; Schulz WA; Häussler J; Melzner I; Brüderlein S; Möller P; Kemmerling R; Vogel W; Hameister H
Cancer Res; 2000 Aug; 60(16):4526-30. PubMed ID: 10969802
[TBL] [Abstract][Full Text] [Related]
3. Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder.
Bruch J; Wöhr G; Brüderlein S; Barbi G; Wolter H; Dixkens C; Mattfeldt T; Möller P; Paiss T; Hautmann R; Vogel W; Hameister H
Int J Cancer; 1999 Mar; 80(6):903-10. PubMed ID: 10074925
[TBL] [Abstract][Full Text] [Related]
4. Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization.
Strefford JC; Lillington DM; Steggall M; Lane TM; Nouri AM; Young BD; Oliver RT
Cancer Genet Cytogenet; 2002 Jun; 135(2):139-46. PubMed ID: 12127398
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric detection of chromosome abnormalities by measuring centromeric index, DNA content, and DNA base composition.
Rens W; Boschman GA; Hoovers JM; Manders EM; Slater RM; Stap J; Aten JA
Anal Cell Pathol; 1994 May; 6(4):359-75. PubMed ID: 8060891
[TBL] [Abstract][Full Text] [Related]
6. Complete characterization of a large marker chromosome by reverse and forward chromosome painting.
Blennow E; Telenius H; Larsson C; de Vos D; Bajalica S; Ponder BA; Nordenskjöld M
Hum Genet; 1992 Dec; 90(4):371-4. PubMed ID: 1483693
[TBL] [Abstract][Full Text] [Related]
7. Detection of genetic aberrations in bladder cancer using in situ hybridization.
Ramaekers FC; Hopman AH
Ann N Y Acad Sci; 1993 Mar; 677():199-213. PubMed ID: 8098592
[No Abstract] [Full Text] [Related]
8. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.
Yu DS; Chen HI; Chang SY
Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044
[TBL] [Abstract][Full Text] [Related]
9. Pure chromosome-specific PCR libraries from single sorted chromosomes.
VanDevanter DR; Choongkittaworn NM; Dyer KA; Aten J; Otto P; Behler C; Bryant EM; Rabinovitch PS
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5858-62. PubMed ID: 8016078
[TBL] [Abstract][Full Text] [Related]
10. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
11. Delineation of marker chromosomes by reverse chromosome painting using only a small number of DOP-PCR amplified microdissected chromosomes.
Viersbach R; Schwanitz G; Nöthen MM
Hum Genet; 1994 Jun; 93(6):663-7. PubMed ID: 8005590
[TBL] [Abstract][Full Text] [Related]
12. Identification and fate of a marker chromosome in methotrexate-resistant V79,B7 cells by flow karyotyping and sorting, metaphase analysis and in situ hybridization.
Nüsse M; Viaggi S; Bonatti S
Anal Cell Pathol; 1992 Sep; 4(5):345-58. PubMed ID: 1445793
[TBL] [Abstract][Full Text] [Related]
13. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer.
Matsuyama H; Bergerheim US; Nilsson I; Pan Y; Skoog L; Tribukait B; Ekman P
Cancer Genet Cytogenet; 1994 Oct; 77(2):118-24. PubMed ID: 7954321
[TBL] [Abstract][Full Text] [Related]
14. DNA flow cytometric analysis and numerical chromosome 9 aberrations detected by interphase cytogenetics in superficial bladder TCC.
Eleuteri P; Grollino MG; Pomponi D; Calugi G; Rocchi M; De Vita R
Eur J Histochem; 1997; 41 Suppl 2():161-2. PubMed ID: 9859830
[No Abstract] [Full Text] [Related]
15. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
16. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
[TBL] [Abstract][Full Text] [Related]
17. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
Shou J; Wang M; Ma J
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
[TBL] [Abstract][Full Text] [Related]
18. Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization.
Yokogi H; Wada Y; Moriyama-Gonda N; Igawa M; Ishibe T
Br J Urol; 1996 Nov; 78(5):699-703. PubMed ID: 8976763
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma.
Eleuteri P; Grollino MG; Pomponi D; De Vita R
Eur J Cancer; 2001 Aug; 37(12):1496-503. PubMed ID: 11506956
[TBL] [Abstract][Full Text] [Related]
20. Generation of five high-complexity painting probe libraries from flow-sorted mouse chromosomes.
Weier HU; Polikoff D; Fawcett JJ; Greulich KM; Lee KH; Cram S; Chapman VM; Gray JW
Genomics; 1994 Jun; 21(3):641-4. PubMed ID: 7959744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
